Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus.
作者信息
Joob Beuy, Wiwanitkit Viroj
机构信息
Sanitation Medical Academic Center, Bangkok, Thailand.
Hainan Medical University, China (Visiting Professor).
出版信息
Turk J Ophthalmol. 2017 Apr;47(2):123-124. doi: 10.4274/tjo.91328. Epub 2017 Apr 1.
Abstract
摘要
相似文献
1
Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus.玻璃体内注射贝伐单抗治疗玻璃体积血与糖尿病
Turk J Ophthalmol. 2017 Apr;47(2):123-124. doi: 10.4274/tjo.91328. Epub 2017 Apr 1.
2
Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.玻璃体腔注射贝伐单抗治疗增殖性糖尿病视网膜病变玻璃体切除术后玻璃体积血后发生的幽灵细胞性青光眼。
Ophthalmic Surg Lasers Imaging. 2010 Jan-Feb;41(1):72-7. doi: 10.3928/15428877-20091230-13.
3
Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.玻璃体腔内注射贝伐单抗（阿瓦斯汀）在糖尿病玻璃体切除术后预防术后复发性玻璃体积血的作用。
Retina. 2010 Nov-Dec;30(10):1646-50. doi: 10.1097/IAE.0b013e3181d6def0.
4
Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study.眼内注射bevacizumab 在伴有致密玻璃体出血的 Eales 病中的作用：一项前瞻性随机对照研究。
Retina. 2011 May;31(5):866-70. doi: 10.1097/IAE.0b013e3181f2a27f.
5
RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.玻璃体腔内注射0.16毫克贝伐单抗在增殖性糖尿病视网膜病变手术前一天进行的随机对照研究。
Retina. 2015 Sep;35(9):1800-7. doi: 10.1097/IAE.0000000000000577.
6
Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.糖尿病玻璃体切除术后玻璃体内注射贝伐单抗预防术后玻璃体出血的比较研究
J Med Assoc Thai. 2012 Apr;95 Suppl 4:S136-42.
7
The role of intravitreal bevacizumab in experimental posterior penetrating eye injury.玻璃体内注射贝伐单抗在实验性后部穿通性眼损伤中的作用。
Retina. 2011 Jan;31(1):154-60. doi: 10.1097/IAE.0b013e3181e096f3.
8
Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.脉络膜新生血管患者玻璃体内贝伐单抗和血管内皮生长因子-A的水平
Ophthalmology. 2008 Oct;115(10):1750-5, 1755.e1. doi: 10.1016/j.ophtha.2008.04.023. Epub 2008 Aug 16.
9
Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.玻璃体内注射贝伐单抗用于新生血管性青光眼患者艾哈迈德青光眼引流阀植入术：一例报告
J Med Assoc Thai. 2008;91 Suppl 1:S162-5.
10
Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者眼内注射贝伐单抗或曲安奈德后的玻璃体介质
Ophthalmology. 2009 May;116(5):921-6. doi: 10.1016/j.ophtha.2008.12.024.
本文引用的文献
1
The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects.玻璃体内注射贝伐单抗治疗糖尿病患者玻璃体积血的疗效
Turk J Ophthalmol. 2016 Oct;46(5):221-225. doi: 10.4274/tjo.82542. Epub 2016 Oct 17.
2
Bilateral concomitant intravitreal anti-vascular endothelial growth factor injection: Experience in a Nigerian tertiary private eye care facility.双眼同时玻璃体内注射抗血管内皮生长因子：尼日利亚一家私立三级眼科护理机构的经验。
Niger J Clin Pract. 2016 Jul-Aug;19(4):544-8. doi: 10.4103/1119-3077.183313.
3
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.全视网膜光凝与玻璃体内注射雷珠单抗治疗增殖性糖尿病视网膜病变的随机临床试验
JAMA. 2015 Nov 24;314(20):2137-2146. doi: 10.1001/jama.2015.15217.
4
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
5
Two cases of acute abdomen after an intravitreal injection of bevacizumab.玻璃体内注射贝伐单抗后出现急腹症的两例病例。
Case Rep Ophthalmol. 2015 Mar 27;6(1):110-4. doi: 10.1159/000381257. eCollection 2015 Jan-Apr.
6
Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.血管内皮生长因子在年龄相关性黄斑变性和糖尿病性黄斑水肿患者玻璃体内注射贝伐单抗、雷珠单抗和聚乙二醇化阿柏西普前后的血浆水平。
Br J Ophthalmol. 2013 Apr;97(4):454-9. doi: 10.1136/bjophthalmol-2012-302451. Epub 2013 Feb 5.
7
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.采用抗血管内皮生长因子疗法治疗糖尿病性黄斑水肿的抗血管生成治疗
Cochrane Database Syst Rev. 2012 Dec 12;12:CD007419. doi: 10.1002/14651858.CD007419.pub3.
Zotero 插件